Methods and compositions for treating ophthalmic conditions with retinyl derivatives
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 2, 2013
Grant Date -
Nov 25, 2010
app pub date -
Apr 21, 2010
filing date -
Jun 23, 2004
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Compounds that cause reversible night blindness may be used to treat ophthalmic conditions associated with the overproduction of waste products that accumulate during the course of the visual cycle. We describe methods and compositions using such compounds and their derivatives to treat, for example, the macular degenerations and dystrophies or to alleviate symptoms associated with such ophthalmic conditions. Such compounds and their derivatives may be used as single agent therapy or in combination with other agents or therapies.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully